Expertise in
31
conditions

Dr. Francisco G. Miranda

Internal Medicine
Cano Health LLC
7306 SW 117th Ave, 
Miami, FL 
Accepting New Patients
Offers Telehealth
Expertise in
31
conditions
Cano Health LLC
7306 SW 117th Ave, 
Miami, FL 

Overview

Francisco Miranda is a primary care provider, practicing in Internal Medicine in Miami, Florida.

Dr. Miranda is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Abetalipoproteinemia, Hypolipoproteinemia, Chorea-Acanthocytosis, and Familial HDL Deficiency.

He is actively involved in clinical research, participating in 13 clinical trials. Dr. Miranda is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Languages Spoken

English
French
Haitian Creole
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Cano Health LLC
7306 SW 117th Ave, Miami, FL 33183

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 2
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses Versus Placebo in Patients With Type 2 Diabetes on Metformin Monotherapy
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Study of Once-Weekly LY3298176 Compared With Placebo and Dulaglutide in Patients With Type 2 Diabetes Mellitus
A Phase 2 Study of Once-Weekly LY3298176 Compared With Placebo and Dulaglutide in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: August 20, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: November 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials
Similar Doctors
Expertise in
6
conditions
Dr. Ravindra J. Ganesh
Internal Medicine
Expertise in
6
conditions
Dr. Ravindra J. Ganesh
Internal Medicine

Baptist Health Concierge Medicine | Coral Gables (Belmont Village)

4101 Salzedo St, 
Coral Gables, FL 
 (8.0 miles away)
786-345-7208
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Ravindra Ganesh is a primary care provider, practicing in Internal Medicine in Coral Gables, Florida. Dr. Ganesh is highly rated in 6 conditions, according to our data. His clinical expertise encompasses COVID-19, Long Haul COVID, Multisystem Inflammatory Syndrome in Children (MIS-C), and Severe Acute Respiratory Syndrome (SARS). Dr. Ganesh is currently accepting new patients.

Expertise in
59
conditions
Dr. Manuel A. Ojeda
Internal Medicine
Expertise in
59
conditions
Dr. Manuel A. Ojeda
Internal Medicine

Select Specialty Hospital-Miami

955 NW 3rd St, 
Miami, FL 
 (12.0 miles away)
305-416-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Manuel Ojeda is a primary care provider, practicing in Internal Medicine in Miami, Florida. Dr. Ojeda is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Necrosis, Painful Swallowing, Swallowing Difficulty, Gastrostomy, and Endoscopy. Dr. Ojeda is currently accepting new patients.

Expertise in
59
conditions
Dr. Sandor A. Romero
Internal Medicine
Expertise in
59
conditions
Dr. Sandor A. Romero
Internal Medicine
Before you request

Fidel Cintas MD PA

8260 W Flagler St Ste 2I, 
Miami, FL 
 (6.2 miles away)
786-715-9183
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sandor Romero is a primary care provider, practicing in Internal Medicine in Miami, Florida. Dr. Romero is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Necrosis, Muscle Atrophy, Peptic Ulcer, Gastrostomy, and Endoscopy. Dr. Romero is currently accepting new patients.

Frequently Asked Questions about Dr. Francisco G. Miranda

How do I make an appointment with Dr. Francisco G. Miranda?

You can book an appointment with Dr. Francisco G. Miranda by calling their office at 305-220-0220. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Francisco G. Miranda a top-rated expert for Abetalipoproteinemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Francisco G. Miranda is classified as an Advanced expert for Abetalipoproteinemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Francisco G. Miranda specialize in?

While Dr. Francisco G. Miranda is a Internal Medicine, they have specific expertise in Abetalipoproteinemia, Hypolipoproteinemia, and Chorea-Acanthocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Francisco G. Miranda accept my insurance?

Dr. Francisco G. Miranda accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 305-220-0220 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Miranda's expertise for a condition
ConditionClose
      View All 31 Advanced Conditions
      View All 137 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile